During the pandemic, Rodrigue started following social media creators posting about losing weight after using drugs like ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Jim Gaffigan has struggled with his weight for most of his adult life, but it seems that his most recent 50-lb weight loss is ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Her primary care doctor had agreed the new class of weight loss drugs might work for her. “I did a series of different kinds of ... the main ingredient in FDA-approved Ozempic and Wegovy— and found it ...

"There’s people walking around that obviously do not have blonde hair – yet they do. I don’t think that’s weird either. It’s ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

(Bloomberg) -- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies ...

LONDON, United Kingdom - AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with ...

Novo and Lilly are also working on oral weight loss drugs. In September, Novo released phase 2b data on monlunabant, a cannabinoid receptor 1 (CB1) inverse agonist, though the results appeared to ...